Science & Medicine
|
|
Bacterial Vaginosis solution for prevention and recurrent symptoms
|
|
antibotter
|
0 |
22 |
0 |
12:23 |
12:23 |
Science & Medicine
|
0
|
22
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Covid
|
|
antibotter
|
44 |
5.5K |
3 |
28/12/24 |
28/12/24 |
ASX - By Stock
|
44
|
5.5K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Predictions for 2025
|
|
antibotter
|
7 |
1.8K |
2 |
26/12/24 |
26/12/24 |
ASX - By Stock
|
7
|
1.8K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Predictions for 2025
|
|
antibotter
|
7 |
1.8K |
3 |
26/12/24 |
26/12/24 |
ASX - By Stock
|
7
|
1.8K
|
3
|
|
ASX - By Stock
|
SPL |
Predictions for 2025
|
|
antibotter
|
7 |
1.8K |
6 |
26/12/24 |
26/12/24 |
ASX - By Stock
|
7
|
1.8K
|
6
|
|
ASX - By Stock
|
SPL |
Re:
Four indications for DEP® cabazitaxel and DEP® SN38
|
|
antibotter
|
14 |
3.8K |
3 |
22/12/24 |
22/12/24 |
ASX - By Stock
|
14
|
3.8K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
UIL Limited increase stake in Starpharma
|
|
antibotter
|
12 |
2.4K |
1 |
22/12/24 |
22/12/24 |
ASX - By Stock
|
12
|
2.4K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Targeted Radiopharmaceuticals Summit Europe. December 3-5 | Amsterdam, the Netherlands
|
|
antibotter
|
17 |
3.4K |
1 |
21/12/24 |
21/12/24 |
ASX - By Stock
|
17
|
3.4K
|
1
|
|
ASX - By Stock
|
SPL |
Four indications for DEP® cabazitaxel and DEP® SN38
|
|
antibotter
|
14 |
3.8K |
4 |
21/12/24 |
21/12/24 |
ASX - By Stock
|
14
|
3.8K
|
4
|
|
ASX - By Stock
|
SPL |
Key Opinion Leader Robert L. Coleman, MD FACOG FACS is the real deal
|
|
antibotter
|
1 |
528 |
3 |
21/12/24 |
21/12/24 |
ASX - By Stock
|
1
|
528
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Targeted Radiopharmaceuticals Summit Europe. December 3-5 | Amsterdam, the Netherlands
|
|
antibotter
|
17 |
3.4K |
2 |
21/12/24 |
21/12/24 |
ASX - By Stock
|
17
|
3.4K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
$2/s is near
|
|
antibotter
|
156 |
82K |
5 |
19/12/24 |
19/12/24 |
ASX - By Stock
|
156
|
82K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Ann: SPL receives positive FDA feedback on DEP SN38 for PROC
|
|
antibotter
|
39 |
8.0K |
4 |
19/12/24 |
19/12/24 |
ASX - By Stock
|
39
|
8.0K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Ann: SPL receives positive FDA feedback on DEP SN38 for PROC
|
|
antibotter
|
39 |
8.0K |
5 |
19/12/24 |
19/12/24 |
ASX - By Stock
|
39
|
8.0K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Ann: SPL receives positive FDA feedback on DEP SN38 for PROC
|
|
antibotter
|
39 |
8.0K |
1 |
19/12/24 |
19/12/24 |
ASX - By Stock
|
39
|
8.0K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Starpharma and Telix (true or false)
|
|
antibotter
|
11 |
7.0K |
3 |
19/12/24 |
19/12/24 |
ASX - By Stock
|
11
|
7.0K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Telix and Starpharma (true or false)
|
|
antibotter
|
57 |
12K |
0 |
19/12/24 |
19/12/24 |
ASX - By Stock
|
57
|
12K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Telix and Starpharma (true or false)
|
|
antibotter
|
57 |
12K |
2 |
17/12/24 |
17/12/24 |
ASX - By Stock
|
57
|
12K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Market competitor news
|
|
antibotter
|
69 |
29K |
0 |
17/12/24 |
17/12/24 |
ASX - By Stock
|
69
|
29K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Market competitor news
|
|
antibotter
|
69 |
29K |
2 |
17/12/24 |
17/12/24 |
ASX - By Stock
|
69
|
29K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Market competitor news
|
|
antibotter
|
69 |
29K |
0 |
17/12/24 |
17/12/24 |
ASX - By Stock
|
69
|
29K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Changes in what Australian doctors can recommend for Covid
|
|
antibotter
|
3 |
747 |
2 |
15/12/24 |
15/12/24 |
ASX - By Stock
|
3
|
747
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Starpharma and Telix (true or false)
|
|
antibotter
|
11 |
7.0K |
3 |
12/12/24 |
12/12/24 |
ASX - By Stock
|
11
|
7.0K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Telix and Starpharma (true or false)
|
|
antibotter
|
57 |
12K |
0 |
12/12/24 |
12/12/24 |
ASX - By Stock
|
57
|
12K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Telix and Starpharma (true or false)
|
|
antibotter
|
57 |
12K |
3 |
11/12/24 |
11/12/24 |
ASX - By Stock
|
57
|
12K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Telix and Starpharma (true or false)
|
|
antibotter
|
57 |
12K |
1 |
11/12/24 |
11/12/24 |
ASX - By Stock
|
57
|
12K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Starpharma and Telix (true or false)
|
|
antibotter
|
11 |
7.0K |
0 |
11/12/24 |
11/12/24 |
ASX - By Stock
|
11
|
7.0K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Starpharma and Telix (true or false)
|
|
antibotter
|
11 |
7.0K |
4 |
11/12/24 |
11/12/24 |
ASX - By Stock
|
11
|
7.0K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Starpharma to rebrand Vivagel
|
|
antibotter
|
17 |
5.3K |
0 |
09/12/24 |
09/12/24 |
ASX - By Stock
|
17
|
5.3K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Telix and Starpharma (true or false)
|
|
antibotter
|
57 |
12K |
3 |
09/12/24 |
09/12/24 |
ASX - By Stock
|
57
|
12K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Starpharma and Telix (true or false)
|
|
antibotter
|
11 |
7.0K |
4 |
09/12/24 |
09/12/24 |
ASX - By Stock
|
11
|
7.0K
|
4
|
|
ASX - By Stock
|
SPL |
Dendrimers in Neurodegenerative Diseases
|
|
antibotter
|
2 |
795 |
3 |
07/12/24 |
07/12/24 |
ASX - By Stock
|
2
|
795
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Targeted Radiopharmaceuticals Summit Europe. December 3-5 | Amsterdam, the Netherlands
|
|
antibotter
|
17 |
3.4K |
2 |
07/12/24 |
07/12/24 |
ASX - By Stock
|
17
|
3.4K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Targeted Radiopharmaceuticals Summit Europe. December 3-5 | Amsterdam, the Netherlands
|
|
antibotter
|
17 |
3.4K |
3 |
06/12/24 |
06/12/24 |
ASX - By Stock
|
17
|
3.4K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Starpharma and Telix (true or false)
|
|
antibotter
|
11 |
7.0K |
7 |
05/12/24 |
05/12/24 |
ASX - By Stock
|
11
|
7.0K
|
7
|
|
ASX - By Stock
|
TLX |
Re:
Starpharma and Telix (true or false)
|
|
antibotter
|
11 |
7.0K |
5 |
05/12/24 |
05/12/24 |
ASX - By Stock
|
11
|
7.0K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Telix and Starpharma (true or false)
|
|
antibotter
|
57 |
12K |
2 |
05/12/24 |
05/12/24 |
ASX - By Stock
|
57
|
12K
|
2
|
|
ASX - By Stock
|
TLX |
Starpharma and Telix (true or false)
|
|
antibotter
|
11 |
7.0K |
3 |
05/12/24 |
05/12/24 |
ASX - By Stock
|
11
|
7.0K
|
3
|
|
ASX - By Stock
|
SPL |
Telix and Starpharma (true or false)
|
|
antibotter
|
57 |
12K |
2 |
05/12/24 |
05/12/24 |
ASX - By Stock
|
57
|
12K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Targeted Radiopharmaceuticals Summit Europe. December 3-5 | Amsterdam, the Netherlands
|
|
antibotter
|
17 |
3.4K |
5 |
03/12/24 |
03/12/24 |
ASX - By Stock
|
17
|
3.4K
|
5
|
|
ASX - By Stock
|
SPL |
Targeted Radiopharmaceuticals Summit Europe. December 3-5 | Amsterdam, the Netherlands
|
|
antibotter
|
17 |
3.4K |
1 |
03/12/24 |
03/12/24 |
ASX - By Stock
|
17
|
3.4K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
COVID-19 wave hits Victoria with cases and hospitalisations on rise ahead of festive season
|
|
antibotter
|
39 |
6.1K |
1 |
02/12/24 |
02/12/24 |
ASX - By Stock
|
39
|
6.1K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
COVID-19 wave hits Victoria with cases and hospitalisations on rise ahead of festive season
|
|
antibotter
|
39 |
6.1K |
2 |
02/12/24 |
02/12/24 |
ASX - By Stock
|
39
|
6.1K
|
2
|
|
ASX - By Stock
|
SPL |
COVID-19 wave hits Victoria with cases and hospitalisations on rise ahead of festive season
|
|
antibotter
|
39 |
6.1K |
1 |
02/12/24 |
02/12/24 |
ASX - By Stock
|
39
|
6.1K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Viraleze approved by TGA Schedue 2
|
|
antibotter
|
45 |
10K |
0 |
01/12/24 |
01/12/24 |
ASX - By Stock
|
45
|
10K
|
0
|
|
ASX - By Stock
|
SPL |
Honouring the Inventor of Dendrimers
|
|
antibotter
|
1 |
1.1K |
2 |
29/11/24 |
29/11/24 |
ASX - By Stock
|
1
|
1.1K
|
2
|
|
ASX - By Stock
|
AAC |
Is Twiggy about to make a full bid for this icon
|
|
antibotter
|
1 |
537 |
0 |
28/11/24 |
28/11/24 |
ASX - By Stock
|
1
|
537
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: AGM Chair's address and CEO's presentation
|
|
antibotter
|
28 |
5.9K |
1 |
27/11/24 |
27/11/24 |
ASX - By Stock
|
28
|
5.9K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
About to break out???
|
|
antibotter
|
23 |
4.5K |
1 |
25/11/24 |
25/11/24 |
ASX - By Stock
|
23
|
4.5K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Starpharma to rebrand Vivagel
|
|
antibotter
|
17 |
5.3K |
0 |
24/11/24 |
24/11/24 |
ASX - By Stock
|
17
|
5.3K
|
0
|
|